Novel neoadjuvant therapy paradigms for bladder cancer: Results from the National Cancer Center Institute Forum Review uri icon

Overview

MeSH Major

  • Clinical Trials as Topic
  • Urinary Bladder Neoplasms

abstract

  • The meeting provided a unique opportunity to launch a collective effort to establish molecular-based therapies for muscle-invasive urothelial cancer. The goal is to use this framework to develop comparable trials with immunotherapy in non-muscle invasive cancers and to exploit the neoadjuvant platform to develop targeted therapy in muscle-invasive disease.

publication date

  • January 2014

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC4262150

Digital Object Identifier (DOI)

  • 10.1016/j.urolonc.2013.10.021

PubMed ID

  • 25443274

Additional Document Info

start page

  • 1108

end page

  • 15

volume

  • 32

number

  • 8